|
N-succinylglycine
|
吡拉西坦雜質(zhì)E
|
5626-41-5
|
|
Apixaban Impurity 21
|
阿哌沙班雜質(zhì)21
|
2435783-75-6
|
|
N,N-diethylpyridine-3-carboxamide 1-oxide
|
3-(二乙基氨基甲?；?吡啶-1-氧化物
|
20165-96-2
|
|
N,N-DiethylisonicotinaMide
|
N,N-二乙基異煙酰胺
|
530-40-5
|
|
Isonicotinic acid
|
異煙酸
|
55-22-1
|
|
(3R,4R,5S)-ethyl 4-acetamido-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
|
磷酸奧司他韋
|
651324-09-3
|
|
5,6-trans-Vitamin D3
|
反式維生素d3
|
22350-41-0
|
|
2,6-Dichlorobenzoic acid
|
2,6-二氯苯甲酸
|
50-30-6
|
|
4-Nitrophenylacetic acid
|
對(duì)硝基苯乙酸
|
104-03-0
|
|
1,2,4-Triazole sodium
|
三氮唑鈉
|
41253-21-8
|
|
(2'R)-N-Benzoyl-2'-deoxy-2'-fluoro-2'-methylcytidine 3',5'-dibenzoate
|
(2'R)-N-苯甲酰基-2'-脫氧-2'-氟-2'-甲基胞苷 3',5'-二苯甲酸酯
|
817204-32-3
|
|
6-METHOXY-2-NAPHTHOIC ACID
|
萘普生雜質(zhì)VI
|
2471-70-7
|
|
(2S,3S)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol
|
艾氟康唑雜質(zhì)48
|
135270-05-2
|
|
(R)-Naproxen
|
L-萘普生
|
23979-41-1
|
|
Benzocaine
|
4-氨基苯甲酸乙酯
|
94-09-7
|
|
25-Deacetyl-23-acetyl RifaMpicin
|
25-去乙酰-23-乙酰利福平
|
1416773-23-3
|
|
25-Desacetyl RifaMpicin
|
25-去乙酰利福平
|
16783-99-6
|
|
Benzaldehyde, 3,5-dibromo-2-nitro-
|
2-硝基-3，5-二溴苯甲醛
|
861787-48-6
|
|
(R)-ethyl N-formyl-N-(1-phenylethyl)glycine
|
依托咪酯INT2
|
66514-85-0
|
|
S-(-)-EtoMidate
|
依托咪酯EM-03
|
56649-47-9
|
|
2-[1-(Mercaptomethyl)cyclopropyl]acetic acid
|
孟魯司特鈉MT-B3
|
162515-68-6
|
|
trans-4-[[(2-AMino-3,5-dibroMophenyl)Methylene]aMino]cyclohexanol
|
反式-4-(((2-氨基-3,5-二溴苯基)亞甲基)氨基)環(huán)己醇
|
50910-53-7
|
|
2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile
|
2-[1-(乙基磺?；?-3-氮雜環(huán)丁亞基]乙腈
|
1187595-85-2
|
|
Pantoprazole Impurity 11 DiHCl
|
4-(二氟甲氧基)-1,2-苯二胺二鹽酸鹽(游離態(tài))
|
97963-77-4
|
|
3-HYDROXY-4-METHOXYPHENETHYLAMINE HYDROCHLORIDE
|
鹽酸多巴胺雜質(zhì)A
|
645-33-0
|
|
Valsartan Impurity 104
|
纈沙坦雜質(zhì)104
|
2459446-56-9
|
|
7-Bromo-2,4-dichloropyrido[3,2-d]pyrimidine
|
7-溴-2,4-二氯吡啶并[3,2-d]嘧啶
|
1215074-41-1
|
|
2,6-dichloro-4-nitrobenzoic acid
|
氯普魯卡因雜質(zhì)a-8
|
22509-50-8
|
|
N-CYANOACETYLURETHANE
|
N-氰基乙酰尿烷
|
6629-04-5
|
|
2,2',3,3'-Tetramethylbiphenyl
|
2,2',3,3'四甲基苯聯(lián)苯
|
7495-46-7
|
|
Polymyxin B3
|
多粘菌素B3
|
71140-58-4
|
|
Polymyxin B1-I
|
多粘菌素B1-I
|
811435-10-6
|
|
Polymyxin B2
|
多粘菌素B2
|
34503-87-2
|
|
Celecoxib Impurity 29
|
塞來(lái)昔布雜質(zhì)29
|
2247197-65-3
|
|
Polymyxin B1
|
多粘菌素B1
|
4135-11-9
|
|
Risedronate EP Impurity C
|
利噻膦酸鈉EP雜質(zhì)C
|
105462-25-7
|
|
Epalrestat (E,E)-Isomer
|
依帕司他雜質(zhì)B
|
863988-85-6
|
|
Propyl 2-bromo-2-methylpropionate
|
2-溴異丁酸正丙酯
|
52890-69-4
|
|
Apalutamide Impurity 2
|
阿帕魯胺雜質(zhì)2
|
1332391-92-0
|
|
Atorvastatin Impurity 4
|
阿托伐他汀雜質(zhì)
|
444577-70-2
|
|
Fluticasone Impurity 1
|
氟替卡松雜質(zhì)1
|
397864-63-0
|
|
Desloratadine Impurity 3
|
地氯雷他定雜質(zhì)3
|
1346600-61-0
|
|
Apalutamide Impurity 6
|
阿帕魯胺雜質(zhì)6
|
|
|
Pregnenolone isobutyrate
|
孕烯醇酮異丁酸酯
|
|
|
Apalutamide Impurity F
|
阿帕魯胺雜質(zhì)F
|
|
|
Apalutamide Impurity 5
|
阿帕魯胺雜質(zhì)5
|
|
|
N-nitroso-mirabegron
|
亞硝胺米拉貝隆
|
|
|
2-Picolinic acid
|
2-吡啶甲酸
|
98-98-6
|
|
Efinaconazole Impurity 41
|
艾氟康唑雜質(zhì)41
|
127001-03-0
|
|
Methyl isonicotinate
|
異煙酸甲酯
|
2459-09-8
|
|
Ethyl nicotinate
|
煙酸乙酯
|
614-18-6
|
|
3,4-Difluoronitrobenzene
|
1,2-二氟-4-硝基苯
|
369-34-6
|
|
Methyl picolinate
|
吡啶甲酸甲酯
|
2459-07-6
|
|
4-(2-fluoro-4-nitrophenyl) Moropholine
|
4-(2-氟-4-硝基苯基)嗎啉
|
2689-39-6
|
|
Lecithin Hydrogenated
|
氫化卵磷脂
|
92128-87-5
|
|
4,7-dibromobenzo[b]thiophene
|
4,7-二溴苯并噻吩
|
1391908-40-9
|
|
Tachysterol3
|
速甾醇
|
17592-07-3
|
|
N,N-Diethylpicolinamide
|
N,N-甲基吡啶-2-甲酰胺
|
7606-13-5
|
|
3-(ethylcarbamoyl)pyridine 1-oxide
|
3-(乙基氨基甲酰基)吡啶-1-氧化物
|
68254-63-7
|
|
N-EthylnicotinaMide
|
N-乙基煙酰胺
|
4314-66-3
|
|
NA
|
依托咪酯INT4-01
|
|
|
NA
|
布南色林INT1-F
|
|
|
Erythromycin A Enol Ether
|
紅霉素A烯醇醚
|
33396-29-1
|
|
ethyl 2, 2,4-trichloro-3- oxobutyrate
|
氨氯地平雜質(zhì)
|
85153-67-9
|
|
rel-(4aR,7aR)-6-Benzyloctahydro-1H-pyrrolo[3,4-b]pyridine
|
莫西沙星雜質(zhì)41
|
161594-54-3
|
|
TROXACITABINE
|
氧代拉米夫定
|
145918-75-8
|
|
3-CHLOROBENZAL CHLORIDE
|
3-氨芐叉二氯
|
15145-69-4
|
|
PUGODPXGSGWWOT-ZDUSSCGKSA-N
|
依非韋倫雜質(zhì)d
|
2125704-30-3
|
|
DEC-POC PMPA
|
|
2820170-87-2
|
|
Enantiomer Efavirenz
|
R-依非韋倫
|
154801-74-8
|
|
Efavirenz Related Compound B (15 mg) ((S,E)-6-Chloro-4-(2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one)
|
依非韋倫雜質(zhì)b
|
440124-96-9
|
|
Efavirenz IP Impurity A
|
依非韋倫雜質(zhì)j
|
353270-77-6
|
|
[4-Chloro-2-[(1S)-3-cyclopropyl-1-hydroxy-1-(trifluoromethyl)-2-propynyl)phenyl]carbamic Acid Methyl Ester
|
依非韋倫雜質(zhì)h
|
211563-40-5
|
|
Efavirenz
|
依非韋倫雜質(zhì)c
|
154598-52-4
|
|
(S)-2-(2-AMINO-5-CHLOROPHENYL)-4-CYCLOPROPYL-1,1,1-TRIFLUOROBUT-3-YN-2-OL
|
依非韋倫雜質(zhì)a
|
154598-58-0
|
|
Acetamide, N-?[4-?[5-?(acetylamino)?-?2-?hydroxyphenoxy]?phenyl]?-
|
對(duì)乙酰氨基酚EP雜質(zhì)O
|
2575516-61-7
|
|
Fosfomycin Trometamol EP Impurity A
|
磷霉素氨丁三醇EP雜質(zhì)A
|
84954-80-3
|
|
NA
|
阿普米司特 APST-ZZ20
|
|
|
bortezoMib iMpurity F
|
硼替佐米雜質(zhì)F
|
|
|
NA
|
阿普米司特 APST-ZZ6
|
|
|
1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanol
|
APSTYL-1-ZZ7（阿普米斯特
|
2055542-18-0
|
|
LZ100674
|
艾普拉唑雜質(zhì)42
|
2288740-67-8
|
|
4-amino-1-[(2R,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
|
拉米夫定非對(duì)映異構(gòu)體
|
131086-22-1
|
|
SE 563
|
依非韋倫雜質(zhì)i
|
174819-21-7
|
|
Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline)
|
依非韋倫雜質(zhì)k
|
391860-73-4
|
|
rac 6-Chloro-1,4-dihydro-4-(1-pentynyl)-4-(trifluoroMethyl)-2H-3,1-
benzoxazin-2-one
|
依非韋倫雜質(zhì)f
|
205755-86-8
|
|
rac Methyl Efavirenz
|
依非韋倫雜質(zhì)g
|
353270-76-5
|
|
(S)-1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol
|
依非韋倫雜質(zhì)e
|
209414-27-7
|
|
N-Acetyl-L-leucine
|
N-乙酰-L-亮氨酸
|
1188-21-2
|
|
Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride)
|
維拉帕米雜質(zhì)F
|
67775-97-7
|
|
VERAPAMIL RELATED COMPOUND B (50 MG) (AL-PHA-[2-[[2-(3,4-DIMETHOXYPHENYL)-ETHYL]METHYLA-MINO]ETHYL]-3,4-DIMETHOXY-ALPHA-(1-METHY-LETHYL)-BENZENEACETONITRILE MONOHYDROCHLORIDE)
|
維拉帕米雜質(zhì)I
|
1794-55-4
|
|
VERAPAMIL RELATED COMPOUND D (50 MG) (5,5'-[[2-(3,4)DIMETHOXYPHENYL)ETHYL]IMINO]BIS[2-(3,4-DIMETHOXYPHENYL)-2-(1-METHYLETHYL)PENTANENI-TRILE] HYDROCHLORIDE)
|
維拉帕米雜質(zhì)M
|
190850-50-1
|
|
Verapamil
|
維拉帕米雜質(zhì)P
|
52-53-9
|
|
Cilnidipine Impurity 2
|
西尼地平片雜質(zhì)4
|
146845-34-3
|
|
Cilnidipine Impurity 3
|
西尼地平片雜質(zhì)6
|
123853-41-8
|
|
P-[[(1S)-2-(6-AMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-phosphonic Acid Monoethyl Ester
|
PMPA單乙酯
|
255525-18-8
|
|
1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine
|
富馬酸伏諾拉生雜質(zhì)Imp-1
|
1610043-62-3
|
|
Ceftazidime Ep Impurity H
|
頭孢他啶雜質(zhì)H
|
1354396-23-8
|
|
Ceftazidime EP Impurity E
|
頭孢他啶雜質(zhì)E
|
102772-66-7
|
|
2-Acetyl-6-methoxynaphthalene
|
萘普生雜質(zhì)I
|
3900-45-6
|